Posted by AGORACOM-JC
at 10:42 AM on Friday, December 20th, 2019
SPONSOR: BetterU Education Corp.
aims to provide access to quality education from around the world.
The company plans to bridge the prevailing gap in the education and job
industry and enhance the lives of its prospective learners by developing
an integrated ecosystem. Click here for more information.
This Edtech Unicorn Turned Profitable After Tripling Its Revenue in FY19
Online education market is expected to grow to $1.96 billion by 2021
52 per cent compounded annual growth from 2016, according to a 2017 report published by Google and research firm KPMG
By: Shreya Ganguly
Increased Internet penetration and availability of smartphones has
made its way into making the world smaller. Technology is also
disrupting the education market where
the former is leveraged to make learning more engaging and reach
students at places with poor schooling infrastructure. One of the giants
in this space, BYJU’s turned profitable and recorded a revenue of INR
1,341 crore for the fiscal year which ended on March 31, 2019. This is
thrice the amount of INR 490 crore in FY18.
According to the edtech Unicorn,
deeper penetration of its services across India and increase in numbers
of paid subscribers are the primary drivers of growth.
“We have exceeded our financial goals that we set at the beginning of
the year. Expanding our base across smaller towns and cities and
introducing new products have been pivotal to our growth. With 60 per
cent of our students based outside the metros, the aspiration and need
for quality learning has never been higher,†said Mrinal Mohit, chief
operating officer, BYJU’s.
BYJU’s Growth In Numbers
According to the company, it recorded a net profit of INR 20 crores
in FY 18-19. Its gross revenues also increased to INR 1480 crores from
INR 520 crores, last fiscal.
BYJU’s claims to have over 40 million registered users and 2.8
million paid subscribers currently. According to the company, the
average number of minutes a student spends on the app has increased from
64 minutes to 71 minutes per day over the last 12 months and the annual
renewal rates are as high as 85%.
“This year, we also launched our product for young learners (Grades
1-3), which completed our learning offerings from grades 1 – 12. We are
also planning to reach out to deeper parts of India by launching
programs in vernacular languages. We strongly believe that we have the
capability to create a global product that can revolutionize learning
for students across the world,†Mohit said.
Future Plans
The company is now aimed at doubling its revenue to INR 3,000 crore
for the current financial year. Apart from this, Mohit also revealed
that the company will also soon launch BYJU’s online tutoring which will
further accelerate growth and profitability for the current fiscal.
Edtech Market in India
The online education market is expected to grow to $1.96 billion by
2021, a 52 per cent compounded annual growth from 2016, according to a
2017 report published by Google and research firm KPMG.
Online disruption in the education market takes the classroom
directly inside the homes of the students thereby getting wider reach.
Apart from this, technological development is making education a more
interactive experience for children, thereby increasing their engagement
rather than one-way classroom lectures. Also, online lectures allow
one-on-one attention to students to help them grow at their own pace.
Currently, apart from BYJU’s notable players such as Unacademy,
Toppr, Safeducate and GradeUp are looking to disrupt the edtech market.
Posted by AGORACOM-JC
at 5:22 PM on Thursday, December 19th, 2019
SPONSOR: Tartisan Nickel (TN:CSE)
Kenbridge Property has a measured and indicated resource of 7.14
million tonnes at 0.62% nickel, 0.33% copper. Tartisan also has
interests in Peru, including a 20 percent equity stake in Eloro
Resources and 2 percent NSR in their La Victoria property. Click her for more information
The future of nickel: tensions, trade bans and technology
It’s an interesting time for nickel on the global markets
Prices have risen dramatically despite trade tensions between the US and China, and are expected to explode as Indonesia and the Philippines prepare for nickel export bans
With increased demand for stainless steel production and recent
developments in technologies such as electric vehicles, demand for
nickel is higher than ever. Unfortunately, this demand is struggling
against an increasingly tightening supply of the essential metal.
In response to the risk of this increasing demand tightening local
supply, the Indonesian government announced in September 2019 a ban on
the export of raw nickel ores, bringing the ban forward from 2022 to
January 2020.
According to GlobalData analyst David Kurtz, this ban is intended to
produce value-added nickel products, stimulate domestic processing of
ore, and make the country a hub for electric vehicle production.
Indonesia is the largest global producer of nickel and a major
supplier of the metal to China’s stainless steel industry; in
anticipation of the ban, Chinese producers are building up nickel
inventories.
This has increased the price of nickel significantly, with prices at
the end of September 2019 reaching more than $16,000 per tonne, an
increase of more than 60% from January. When the ban was announced,
nickel prices increased by 8.8% to reach a peak of $18,620 per tonne,
the highest price since 2014.
While over half of Indonesia’s nickel is processed in the country,
around 218,000 tonnes of the metal is unprocessed and would be affected
by the ban, which represents around 10% of global demand.
Concerns over supply have led to LME nickel warehouse stock levels
dropping by almost 50% since the announcement of the ban, with Reuters reporting that stocks have fallen to 79,800 tonnes, the lowest since January 2009, as of 24 October 2019.
Potential for the Philippines?
The mining sector in the Philippines is expected to benefit from the
supply gap created by this export ban, with the country’s nickel
industry having suffered in recent years.
As the second-largest producer of nickel, the Philippines accounted for nearly 16% of global production in 2018.
However, production volumes fell sharply in 2016 when the country’s
Department of Environment and Natural Resources launched an audit
process for over 40 metallic mines, resulting in a number of suspensions
and 27 closures. Of these 27 mines, 19 were involved in nickel
production, resulting in a drop in nickel production of over 100kt.
Since the shutdowns, output has steadily increased but has become
dependent on a smaller number of operations, particularly in the mining
region of Caraga. According to Kurtz, the ban in Indonesia “paves the
way for higher exports of nickel from the Philippines to China.â€
However the shutdowns in the Philippines, as well as the lower
quality of nickel ore in the Philippines compared to Indonesia, are
expected to challenge this financial growth. The lower grade of nickel
ore in the Philippines is a particular problem for Chinese operators, as
it affects the ability of nickel pig iron producers to achieve the
necessary purity mix for stainless steel production.
With China being a significant importer of nickel, particularly for
its stainless steel production, the ongoing trade dispute between the US
and China has had a considerable influence on nickel prices.
Prior to the announcement of Indonesia’s export ban, nickel prices
fell steeply in the second half of 2018, but has eased in anticipation
of trade talks later in 2019. Indonesia’s export ban has also allowed
the price of nickel to fare better than other metals such as copper,
avoiding the longer-term financial concerns seen across the resources
sector.
Future prospects
Primary nickel production is forecast to rise by 9-10% in 2019 to
reach 2.4MT, primarily driven by an increase in Indonesia from rising
production in new mines. Demand for nickel in China is expected to grow
over 2.1Mt, as opposed to the 1.6Mt estimated for 2019.
According to analytics from GlobalData, the number of electric
vehicles is expected to increase from 1.6 million in 2018 to 6.8 million
in 2023, and the demand for nickel for lithium-ion batteries is
expected to quadruple over this period from 3-4% in 2019.
With the export bans in place, nickel prices are expected to remain
high while stocks remain low. However, any escalation of the trade
tensions between the US and China could lead to a fall in prices, and
there remains the possibility of Indonesia relaxing their export ban (as
it did previously in 2017 for a ban established in 2014).
This reversal applied to operators working on building processing
capacity, and came about due to losses incurred by stated-owned nickel
exporter PT Aneka Tambang as well as a need to ease the country’s budget
deficit.
Posted by AGORACOM-JC
at 4:29 PM on Thursday, December 19th, 2019
SPONSOR:ThreeD Capital Inc. (IDK:CSE)
Led by legendary financier, Sheldon Inwentash, ThreeD is a
Canadian-based venture capital firm that only invests in best of breed
small-cap companies which are both defensible and mass scalable. More
than just lip service, Inwentash has financed many of Canada’s biggest
small-cap exits. Click Here For More Information.
Gaming Is Key to the Mass Adoption of Crypto
A whole new exciting world of value is being coded into life right now by gamers
While it may be a far cry from the lofty ideals of banking the unbanked and taking down the global banking system, gaming is gearing up to be a massive force in the crypto space
A whole new exciting world of value is being coded into life right
now by gamers. While it may be a far cry from the lofty ideals of
banking the unbanked and taking down the global banking system, gaming
is gearing up to be a massive force in the crypto space.
Addictively fun games will draw a whole new base of users into the
crypto economy. Gamers are an excellent target market for adoption
because many gamers are a touch more tech savvy than the average
internet user and tend to be a bit more open to new ideas.
Just imagine this — a gamer beating a monster, picking up a rare item, selling that item for Ether (ETH)
on a secondary market, and then using that Ether to buy a new hat
online. This creates a whole new network of value that is liquid, fast
and global — and most importantly, taps into gamers’ existing behavior:
playing games.
But for this exciting future to transpire, games need to be fun…
addictively fun. Up until now, most crypto games have been little more
than retro 1980s throwbacks — with very simple graphics and limited
playability — which is nice for nostalgia but will not add anything
significant to the crypto economy. However, a new class of games is
changing this scenario and is set to take crypto games into the leagues
of the truly great online games.
NFTs pave the way
Before looking at some examples, it is important to note that all of
this has been enabled by nonfungible token technology, which allows for
the proliferation of in-game digital assets on public blockchains.
Gaming could possibly be one of the major contributors to the crypto
economy, with game developers making new token standards and technical
developments that benefit the entire ecosystem — as well as the players
of these games generating significant on-chain activity that helps to
feed the miners. So, let us not make the mistake of thinking that crypto
games are not lifting their weight in terms of ecosystem development.
Here are a couple of examples of what is being built and played.
Gods Unchained is bringing the wonder and excitement of a collectible
card game like Magic: The Gathering to Ethereum. Gods Unchained is
graphically enticing and has a great in-game flow of animations that
keep the action rolling. The game has already attracted thousands of players
to tournaments and continues to find a growing community of
enthusiasts. Under the hood, players own the cards that they play with,
storing the unique nonfungible tokens in their Ethereum wallet. Rarity
is provable on-chain, and swaps on the secondary market are seamless. In
February, a card sold for $62,000, which is astonishing for such a new game and really underlines the excitement building around crypto games.
Then, there is the Enjinverse, which is a growing multi-game
experience that allows for in-game items to be used and moved seamlessly
between dozens of games. Enjin itself is one of the most important
cryptocurrencies in the gaming realm. One of the most interesting games
in the Enjinverse is Age of Rust, which is a post-apocalyptic sci-fi
adventure with stunning graphics and an enticing story. Looking at the
popularity of games like Dead Space or Fallout, it becomes clear that
Age of Rust stands a good chance of gaining significant popularity.
While the game itself is exciting, it is the underlying tech that
really makes Age of Rust stand out: Not only are Enjin assets
interoperable between games, but they also have value baked into them.
So, regardless of the long-term outcome of the game itself, the items
you acquire in the game all are forged with Enjin tokens melted into the
in-game asset. These assets can be melted back down at any time,
enabling you to claim the tokens underpinning the value of the item — as
well as creating increased scarcity for the item class, as once it is
melted, that item it gone forever.
Here are some major players to watch. Enjin is working closely with
Unity, which accounts for nearly half of all game developers globally.
Cocos has 1.4 million game developers using its engine, and the launch
of its blockchain is likely to bring many of those developers over. Loom
is focused on interchain operability and on enabling fun, user-facing
games that will draw more users into crypto — with such titles as Neon
District, which is a Blade Runner-esque RPG.
According to the recent research
conducted by a gaming and e-sport analytics provider, the gaming
industry as a whole is expected to be worth $180 billion by 2021, so the
opportunity for crypto gaming is massive. For players, there will be
better experiences; for developers, there will be more tools to attract
players to their games; and for investors, there will be the ability to
own the cryptos that will be at the forefront of a major trend — but
that has not yet taken off.
Posted by AGORACOM-JC
at 3:52 PM on Thursday, December 19th, 2019
SPONSOR: CardioComm Solutions (EKG: TSX-V)
– The heartbeat of cardiovascular medicine and telemedicine. Patented
systems enable medical professionals, patients, and other healthcare
professionals, clinics, hospitals and call centres to access and manage
patient information in a secure and reliable environment.
What’s App? – End of Year Round-up on mHealth App Developments
Advantages of mHealth apps include streamlining the exchange of health information and a better user experience
From a data perspective, apps can use big data to analyse unstructured data and identify patterns and environmental factors that will improve patient treatment
An Irish Times special report estimates that over seven million
patients worldwide are actively using digital health apps as part of
their care plan. The availability of remote and mobile healthcare
solutions relating to fitness, wellbeing, health and medical treatment
could be life-changing for those living in countries lacking easy access
to medical care.
Advantages of mHealth apps include streamlining the exchange of
health information and a better user experience. From a data
perspective, apps can use big data to analyse unstructured data and
identify patterns and environmental factors that will improve patient
treatment.
Government adoption
With this in mind, many governments are encouraging the uptake of mHealth apps.
In the UK, the NHS website has a digital library showcasing mHealth
apps. It lists mHealth apps that have been deemed as clinically safe.
The functionality of the apps is varied and provides services like
repeat prescriptions services, speech and language therapy, and instant
access to medical records. Patients can even use certain apps to monitor
their conditions such as diabetes.
The HSE in Ireland is following the lead of the NHS. It is working
with Orcha, a company that reviews health apps, to provide an Irish
eHealth app library that lists apps reviewed by Orcha.
Orcha assesses mHealth apps’ data use policies and compliance with
relevant standards. It rates the app out of a maximum score of 100, with
a lower score indicating that there may be issues that the user should
investigate before using the app. Clinical assurance and user experience
are also rated to help users and clinicians compare mHealth apps.
The Irish eHealth app library to date lists over 700 mHealth apps.
The HSE points out that the library is a tool for users to identify and
compare apps themselves but it is not intended to promote or recommend
any particular app.
Other developments
Other recent developments in the mHealth sector include:
A WhatsApp style messaging app developed by junior doctors that the
developers claim could save the NHS £44m a year. The app helps NHS
workers exchange patient information, make clinical decisions, manages
their workload in a legally compliant forum and removes the need for
pagers. Currently more than 100 NHS hospitals and care commissioning
groups in the UK are using the app.
An app that monitors children’s temperature. It uses a patch to
wirelessly monitor the baby’s temperature and sends alerts to
smartphones. Unlike a typical thermometer, children do not have to be
woken from their sleep to obtain temperature readings.
Tablets with micro ingestible sensors embedded in the pills that can
alert smartphones when the pills touch the stomach lining of patients.
The developers believe this could be useful for the treatment of mental
illnesses if medication compliance is proving difficult. It could also
be an invaluable tool for pharmaceutical companies or medical
institutions to record timings of ingestion of medications during
clinical trials.
A device and accompanying app that takes ECG recordings via
electrodes. The AI system of the software performs an automatic analysis
and informs the patient of their heart rhythm. This data can then be
sent directly to the patient’s clinician for further analysis and
consultation. The product has already launched in the UK.
A skin mapping app that incorporates AI technology. The app is
designed to detect new moles or marks on the skin. These are one of the
most common warning signs of melanoma and early detection can improve
the success rate of treatment.
Adia Health provides at-home finger prick fertility blood tests, a
preconception plan to help improve fertility health and access to
fertility specialists remotely.
At a broader level, technologies like blockchain, the Internet of
Things and AI / augmented reality are taking mHealth to the next level.
Despite this, the technological advancement and wider adoption of
mHealth apps brings important legal responsibilities. From a medical
standpoint, mHealth apps can be very useful, but they can never replace
the advice of someone’s own clinician.
Regulatory considerations
Depending on their functionality, some mobile apps and standalone
software may fall within the definition of a ‘software medical device’.
Any mHealth app deemed to be a software medical device will be subject
to onerous obligations regarding safety, compliance and post market
surveillance.
Earlier this year, the British Medical Journal warned that popular
mHealth apps may not be keeping personal data about medical conditions
confidential and users may not be aware of how the data they provide on
these apps is being shared.
In Ireland, mHealth apps must comply with laws like the General Data
Protection Regulation (GDPR) and the Irish Data Protection Acts 1988 –
2018. The Data Protection Acts transpose into Irish law the EU’s Law
Enforcement Directive and adopt specific rules to regulate the
processing of personal data for the purposes of health research.
At a basic level, mHealth apps that process personal data revealing
information about an individual’s health will attract more stringent
data protection obligations as this data is ‘special category data’
under data protection law. Processing any special category data is only
allowed in the limited circumstances set out in Article 9 of the GDPR.
As the vast majority of mHealth apps are designed to operate online
they are vulnerable to cyber-security threats. The GDPR make it
essential for a data controller to adopt robust security practices for
personal data, which may include pseudonymising or encrypting it.
Code of Conduct on privacy for mHealth apps
The Code of Conduct on privacy for mHealth apps aims to regulate and
secure the personal data gathered by mHealth apps and promote trust
among users. The Code has not yet been approved and the European
Commission is working with industry stakeholders to encourage the
further development of the current draft Code.
What the future holds
There have been many new developments in 2019 in the mHealth app
sector. It is reassuring that governments are encouraging more
widespread adoption of digital healthcare solutions by healthcare
practitioners and individuals. However, if mHealth apps are to truly
flourish, individuals must trust the mHealth industry and how it is
regulated.
Many mHealth apps have access to vast amounts of sensitive health
information. There are important data protection implications if special
category data relating to individual’s health is collected and
processed. Given the increased privacy and security risks, tech
companies and app developers must be aware of the data protection laws
and ensure they are complying with them. From a transparency
perspective, they should also ensure users are aware of how the data
they provide on mHealth apps is being shared.
From a regulatory point of view, it would be prudent for tech
companies and app developers to determine if an app is a software
medical device. If so, they should ensure they are meeting their
obligations regarding safety, compliance and post market surveillance
and keep up to date with regulatory changes due to take effect next
year.
We also hope 2020 brings progress in finalising the draft Code of
Conduct on privacy for mHealth apps that will set out practical guidance
for app developers on data protection principles when developing
mHealth apps.
Tags: EKG, mhealth, small cap stocks, stocks, tsx, tsx-v Posted in CardioComm Solutions | Comments Off on CardioComm Solutions $EKG.ca – What’s App? – End of Year Round-up on #Mhealth App Developments $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca
Posted by AGORACOM-JC
at 12:29 PM on Thursday, December 19th, 2019
SPONSOR: BetterU Education Corp.
aims to provide access to quality education from around the world.
The company plans to bridge the prevailing gap in the education and job
industry and enhance the lives of its prospective learners by developing
an integrated ecosystem. Click here for more information.
Indian EdTech Unicorn Byju’s Lands $540M to Expand Globally
Indian Edtech firm Byju’s has raised $540 million in funding round led by South Africa’s Naspers Ventures and the CPP Investment Board, the Canada Pension Plan Investment Board.
With this investment, it is aiming to become the world’s most valuable education technology business.
by StartupWorld Staff       Â
Before one year ago, Byju’s revenue expanded to $208 million from $73.2 million. Earlier this year, the Bangalore headquartered startup valued to $5.75 billion in its preceding financing round. By March 31, 2020, it is going to double its income to $422 million. With this new investment, Byju’s will come in the ranking top valuable startups in India like Paytm, Oyo, and Ola.
Founded in 2011 by Byju Raveendran,
Byju’s has become quite popular among students in India. It mainly
focuses on maths and science subjects and around 35 million students in
India are using the app. It has app felicitating Indian regional
languages, and it is also aiming to launch its new version app for
English speaking students in other countries in 2019.
Byju’s had reported a net loss of $4
million on revenue in the last fiscal year. However, this financial year
is very profitable for the company including taxes and all other
expenses in its net profit.
Byju’s simplifies the process of
learning complex subjects to students through its app. The tutors
explain tough theories and calculations through day-to-day experiences.
Currently, it has 2.8 million paying subscribers and 40 million
registered students globally. The app helps students who are pursuing
undergraduate and graduate courses. Besides, it is gaining more
popularity in small towns in India.
Chief operating officer of Byju’s Mrinal Mohit
said that the startup is going to analyze more new products along with
‘Online Tutoring’ to expand its growth and get more profits in the
coming year.
As part of the global expansion, the
startup is planning to enter some of the countries such as the US, UK,
Australia, and New Zealand. This year, it acquired Osmo, a Palo-Alto
based education startup for $120 million. Osmo is popular among 5 to 12
age group children in the US.
Posted by AGORACOM-JC
at 11:47 AM on Thursday, December 19th, 2019
Signed an agreement with Endocanna, to licence and distribute Endo.dna™ test kits through its network of clinics and market directly to the Company’s 165,000 patient database, and as a standard offering in the Sun Valley Health franchise program
Company plans to partner with Endocanna for their Endo.Aligned™ Formulations program to create, manufacture, produce and distribute specialized CBD based products utilizing the Company-Heritage joint venture extraction centre in Sandy, OR.
VANCOUVER, BC / December 19, 2019 / Endocanna Health Inc. (“Endocanna“), a research and development biotechnology company specializing in endocannabinioid DNA testing, and a partly owned subsidiary of Heritage Cannabis Holdings Corp. (CSE:CANN) (“Heritage“) partners with Empower Clinics to distribute Endo.dna™ test kits and develop Endo.Aligned™ product formulations.
EMPOWER CLINICS INC. (CSE:CBDT) (OTC:EPWCF) (Frankfurt:8EC) (“Empower” or the “Company“), a vertically integrated and growth-oriented CBD life sciences company, is pleased to announce it has signed an agreement with Endocanna, to licence and distribute Endo.dna™ test kits through its network of clinics and market directly to the Company’s 165,000 patient database, and as a standard offering in the Sun Valley Health franchise program.
In addition, the Company plans to partner with Endocanna for their Endo.Aligned™
Formulations program to create, manufacture, produce and distribute
specialized CBD based products utilizing the Company-Heritage joint
venture extraction centre in Sandy, OR.
“Empower with its clinic network, large patient base and numerous
physicians are an ideal distribution partner for Endocanna,” said Steven
McAuley, Empower’s Chairman and CEO. “As we strive to be a leader in
patient care and efficacy, having deeper insights about our patients
unique DNA profile allows our physicians to provide even more effective
cannabis based treatment options. Then, translating that knowledge into
new product formulations with Endocanna, will greatly enhance the
long-term shareholder value we are creating.”
“We are pleased to collaborate with a life sciences company like
Empower to develop a custom endocannabinoid-based therapeutic efficacy
model,” says Len May, Endocanna Health CEO and founder. “Our goal at
Endocanna Health is to identify and optimize cannabinoid-based therapies
based on an individual’s DNA while mitigating potential adverse-events
and drug interactions. The data will support DNA validation along with
peer-to-peer efficacy feedback, and provides key data to support our
mission in facilitating the highest quality, consistent, personalized,
endo-aligned cannabinoid products.”
The Endo·dna test analyzes specific DNA markers to provide a
personalized report, Endo·Decoded, that can help guide decisions for
choosing the right cannabinoid products with the right:
Formulation – full-spectrum or broad-spectrum
Dose – the amount you take and when you take it
Delivery – flower, aerosol, vaping, sublingual (under the tongue), topical, or edible
The Endo·Decoded report helps consumers uncover optimal cannabinoid
ratios and terpene profiles for their specific genetic makeup.
Endocanna’s customized endocannabinoid genomics super-chip and algorithm
provides consumers with:
Ideal cannabinoid ratios and terpene profiles, methods of delivery or consumption, and dosing.
Suggestions for specific terpenes and cannabinoids to seek out or to avoid.
Individualized risks or benefits from using cannabinoids.
Suggestions commercially available products and brands most aligned with individual genetics and formulations suggestions.
ABOUT EMPOWER CLINICS INC.
Empower is a leading owner/operator of a network of physician-staffed
clinics focused on helping patients improve and protect their health
through innovative uses of medical cannabis. It is expected that
Empower’s proprietary product line “Sollievo” will offer patients a
variety of delivery methods of doctor recommended cannabidiol (CBD)
based product options in its clinics, online and at major retailers.
With over 165,000 patients, an expanding clinic footprint, a focus on
new technologies, including tele-medicine, and an expanded product
development strategy, Empower is undertaking new growth initiatives to
be positioned as a vertically integrated, diverse, market-leading
service provider for complex patient requirement’s in 2019 and beyond.
ABOUT ENDOCANNA HEALTH INC.
Endocanna is a biotechnology research company that utilizes a
patent-pending process for its cannabinoid DNA variant report,
Endo·Decoded™ and product- matching algorithm, Endo·Aligned™. Endo·dna™
provides two ways to submit DNA for analysis, either collected through a
simple saliva swab or a direct upload of genetic data files from
popular DNA testing services like Ancestry, 23andMe, Family TreeDNA, or
MyHeritageDNA. Endocanna’s HIPAA compliant and secure health and
wellness portal, Mydna.live, provides customers with a personalized
experience where they can access their Endo·Decoded report and
Endo·Aligned formulation suggestions for their specific genotype. In
2019, cannabis producer Heritage Cannabis Holdings (CSE:CANN)(OTC:HERTF)
acquired a 30 percent stake in Endocanna Health Inc.
ON BEHALF OF THE BOARD OF DIRECTORS:
Steven McAuley Chief Executive Officer
CONTACTS:
Investors: Steve Low Boom Capital Markets [email protected] 647-620-5101
For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-MARI
DISCLAIMER FOR FORWARD-LOOKING STATEMENTS
This news release contains certain “forward-looking statements”
or “forward-looking information” (collectively “forward looking
statements”) within the meaning of applicable Canadian securities laws.
All statements, other than statements of historical fact, are
forward-looking statements and are based on expectations, estimates and
projections as at the date of this news release.Forward-looking statements
can frequently be identified by words such as “plans”, “continues”,
“expects”, “projects”, “intends”, “believes”, “anticipates”,
“estimates”, “may”, “will”, “potential”, “proposed” and other similar
words, or information that certain events or conditions “may” or “will”
occur. Forward-looking statements in this news release include
statements regarding: endocanna agreement; the Company’s intention to
open a hemp-based CBD extraction facility; the expected product
development and manufacturing; the expected benefits to the Company and
its shareholders as a result of the proposed JV. Such statements are
only projections, are based on assumptions known to management at this
time, and are subject to risks and uncertainties that may cause actual
results, performance or developments to differ materially from those
contained in the forward-looking statements, including that: Heritage
and Empower may be unable to agree on terms of a definitive agreement
with respect to the JV; that the Company may not open a hemp-based CBD
extraction facility; that legislative changes may have an adverse effect
on the Company’s business and product development; that the Company may
not be able to obtain adequate financing to pursue its business plan;
general business, economic, competitive, political and social
uncertainties; failure to obtain any necessary approvals in connection
with the proposed JV or extraction facility; and other factors beyond
the Company’s control. No assurance can be given that any of the events
anticipated by the forward-looking statements will occur or, if they do
occur, what benefits the Company will obtain from them. Readers are
cautioned not to place undue reliance on the forward-looking statements
in this release, which are qualified in their entirety by these
cautionary statements. The Company is under no obligation, and expressly
disclaims any intention or obligation, to update or revise any
forward-looking statements in this release, whether as a result of new
information, future events or otherwise, except as expressly required by
applicable securities laws.
SOURCE: Endocanna Health Inc.
Tags: CSE, Hemp, Marijuana, stocks, tsx, tsx-v, weed Posted in Empower Clinics Inc. | Comments Off on Empower Clinics $CBDT.ca Completes Agreement With Heritage Cannabis Subsidiary Endocanna Health $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca
Posted by AGORACOM-JC
at 9:31 AM on Thursday, December 19th, 2019
As 2019 comes to a close, sit back and watch CEO Paul Gill provide a compelling year-end recap. With a high grade graphite resource already in place, growing and situated in North America, Lomiko Metals (LMR:TSXV) believes it is on the verge of becoming a supplier to multiple gigafactories being built in North America to support the electric vehicle boom.
Posted by AGORACOM-JC
at 1:39 PM on Wednesday, December 18th, 2019
SPONSOR: CardioComm Solutions (EKG: TSX-V)
– The heartbeat of cardiovascular medicine and telemedicine. Patented
systems enable medical professionals, patients, and other healthcare
professionals, clinics, hospitals and call centres to access and manage
patient information in a secure and reliable environment.
Remote Patient Monitoring, Reimbursement Topped Headlines in 2019
Top mHealth trends in 2019 included remote patient monitoring,
telehealth reimbursement, substance use disorder care, chronic disease
management, and direct-to-consumer mHealth technology.
Based on our most clicked stories in 2019, those trends included remote patient monitoring, telehealth reimbursement and coding, behavioral health/substance use disorder care, chronic disease management strategies, and direct-to-consumer mHealth technologies.
As 2019 comes to an end, healthcare organizations are
reflecting on the trends and stories that most influenced their
behaviors in the past year. Based on our most clicked stories in 2019,
those trends included remote patient monitoring, telehealth
reimbursement and coding, behavioral health/substance use disorder care,
chronic disease management strategies, and direct-to-consumer mHealth
technologies.
In the following article, mHealthIntelligence.com will break down these trends, as well as the strategies and best practices industry leaders developed in response.
Remote patient monitoring
In 2019, healthcare organizations looked to invest in remote
patient monitoring (RPM) solutions to transition to value-based care.
Many healthcare leaders expected these solutions to support high-risk
chronically ill patients whose conditions are considered unstable and at
a risk for hospital admission.
Specifically, 88 percent of providers who were surveyed by health IT thought leaders earlier this year had invested or were evaluating investments in RPM technologies.
RPM solutions have been proven to be clinically effective as an
early symptom management tool for chronically ill patients, who
represented about 45 percent of the US population according to the
survey. These solutions allowed risk-bearing organizations to remotely
monitor patients with chronic conditions to help control healthcare
costs, improve care quality, and increase access to care for patients in
underserved areas.
In addition, these solutions helped manage value-based risk associated with large patient populations with chronic conditions.
“The ability of the device to simultaneously record multiple
variables such as heart rate and accelerometer data allowed us to more
accurately determine the patient’s state, whether he/ she is active,
sedentary, asleep, or not currently using the device,†the researchers
reported.
Because remote patient monitoring is becoming more widespread,
more healthcare organizations are implementing RPM into their health
systems. Recently, Humana announced
a partnership with Philips Health to launch a remote member monitoring
pilot for certain Medicare Advantage members with severe congestive
heart failure (CHF).
“Our goal is to continue to find ways to help our Medicare
Advantage members stay longer and safer in their homes,†Susan Diamond,
president of Humana’s Home Business segment, said in a press release.
Telehealth reimbursement and coding
Along with remote patient monitoring, telehealth has been
extremely vital for healthcare in 2018 and will continue to play a
significant role going into the new year. But healthcare organizations
are still waiting on reimbursement and billing policies to catch up to
telehealth adoption..
One of the top read stories from 2019 was the American Medical
Association’s (AMA) creation of new codes for the use of telehealth and
behavior assessment and intervention services. These codes “more
accurately reflect current clinical practice that increasingly
emphasizes interdisciplinary care coordination and teamwork with
physicians in a primary care and specialty setting,†the association
stressed.
The goal for the new codes was to expand pathways for
physicians across the US who deal with diverse patients, including those
from underserved areas, and those who have any access to care they may
need.
CMS has followed suit, implementing the
AMA and its Digital Medicine Payment Advisory Group to include new
telehealth codes in the 2018 Medicare physician fee schedule. And in the
beginning of this year, CMS released its 2020 physician fee schedule
that included numerous additions that will enable more reimbursement for
connected health services next year.
In October of this year, Pennsylvania tried again to pass comprehensive telehealth legislation after the bill was denied last year because of disagreements over payment parity.
State Senator Elder Vogel introduced The Telemedicine Act (SB
857), which aimed to establish definitions for telemedicine and
telehealth, provide temporary evaluation and treatment guidelines for
reimbursement, and give state departments up to two years to draft
permanent rules and regulations.
The new bill includes remote patient monitoring technologies,
which gives providers the opportunity to use these connected health
services. About a dozen states have passed legislation demanding payment
parity for telehealth, but most have failed because of strong
opposition from healthcare payers.
Addressing substance abuse using mHealth
An estimated
115 people die each day from opioid abuse, an issue that has become
more widespread in the past decade. Healthcare providers have been
actively searching for a solution to tackle this issue, and many have
found a pathway to success using mHealth and telehealth technology.
Applying MHealth and telehealth technology to addiction treatment is expected
to make one of the biggest impacts on substance use disorder care.
Connected health platforms allow providers to work with the individual
patient anytime they need to, and are able to see what the patient
experiences each day.
“We’re building a panoramic view of your life,†said Jacob
Levenson, CEO of MAP Health Management, a Texas-based national network
of almost 100 addiction treatment providers. The organization has
adopted digital health tools for care management and coordination of
substance use disorder patients.
The smartphone is also a great tool for addiction treatment, as it offers both
a platform for population health programs and individual treatments.
Healthcare providers are able to send out messages offering support or
information via text, SMS, or e-mail to large groups at any time. They
can also personalize messages for individuals, connecting information to
one’s habits, location, or medical record.
MHealth apps are becoming increasingly more popular tools. Apps
could feature surveys, messaging or chat rooms, links to resources,
messaging with care providers or a substance abuse specialist, and a 911
link for immediate help.
“Medical devices, including digital health devices like mobile
medical apps, have the potential to play a unique and important role in
tackling the opioid crisis,†FDA Commissioner Scott Gottlieb, MD, said
in a press release
featured on the FDA website. “We must advance new ways to find tools to
help address the human and financial toll of opioid addiction.â€
Chronic disease management strategies
While MHealth platforms were important for addressing the
opioid crisis, the solutions have also been useful for chronic disease
management. A growing number of Americans are suffering from more than
one chronic condition, prompting more healthcare providers to take the
appropriate measures to tackle this issue in 2019.
For example, in January, Omada Health, a digital therapeutics
company that focuses on obesity-related chronic conditions, created a
cognitive behavioral therapy program (CBT) for those dealing with
depression and anxiety.
“Depression and anxiety are a known barrier to healthy
behaviors including medication adherence, optimal nutrition, and seeking
timely preventive care. With the addition of CBT curriculum, we can
more fully support our participants as they manage their conditions.
And, through our digital platform, we can do it at scale,†Carolyn
Bradner Jasik, MD, Omada’s Vice President of Medical Affairs, explained
in a press release.
The challenge going into the coming years is developing a
digital health platform that is able to integrate different programs and
allow for easy access for both patients and providers.
A few weeks ago, a Pennsylvania health system also created a telehealth and remote patient monitoring platform
to allow patients living with ALS to receive at home care. Most
patients with ALS have to travel hours for meetings with doctors and
specialists, which can prove to be challenging. But the telehealth
platform allows the meetings to be held at home.
Heart failure (HF) patients receiving targeted virtual behavior
therapy found significant improvements in self-care, a recent study published in
the journal Circulation found. The study conducted by Humana and AbleTo
found a correlation between improving behavioral health care and
co-existing physical conditions. The study also noted improvements in
self-care, depression symptoms, and awareness of physician
recommendations among patients that received HF-focused virtual
behavioral therapy over eight weeks.
Chronic disease management is vital to reduce costs by
addressing the patient’s illness or condition with maximum clinical
outcomes, while helping beneficiaries control their disease in an
effective way.
Direct-to-consumer mHealth technology
The healthcare industry is facing major disruption from
non-traditional companies, like Amazon, Google, and Apple. The mHealth
space has been no different according to the top stories from 2019.
In September of this year, Amazon prepared to take on the direct-to-consumer telehealth industry through its new platform,
Amazon Care. Amazon Care is a virtual care clinic offering telehealth
and mHealth services for its employees in the Seattle area, including
on-demand access to a clinician online messaging for healthcare
questions, a prescription service, and the option of scheduling an
appointment through Seattle-based Oasis Medical.
Apple Watch can be used by clinicians to detect atrial
fibrillation. But will care providers rely on these devices to present
them with accurate information?
A survey of
420,000 individuals conducted by researchers at the Stanford University
School of Medicine found that over an eight month span, the Apple Watch
detected an irregular heart rate in .52 percent of individuals or 2,161
people. And almost three-quarters of the users who were notified about
an irregular pulse contacted a care provider for further treatment.
“The study’s findings will help patients and clinicians
understand how devices like Apple Watch can play a role in identifying
atrial fibrillation, a deadly and often undiagnosed disease,†Mintu
Turakhia, MD, an associate professor of cardiovascular medicine, said in
the press release.
“Additionally, these important findings lay the foundation for further
research into the use of emerging wearable technologies in clinical
practice and demonstrate the unique potential of large-scale app-based
studies.â€
In addition, a Gallup survey this month showed that nearly one
in five Americans are using an mHealth wearable. Adults younger than 55
are twice as likely to use or have used mHealth. And individuals older
than 55 and women, are more interested in using mHealth than men. About
half of the women respondents under 55 said they use or have used
mHealth in the past. While men over age 55 are the least likely to use
or have used the technology.
Jefferson Health recently partnered
with Quick’r Care to create a mHealth platform to allow patients to
choose their correct care path. Through JeffConnect’s virtual care
service. Consumers will have on-demand video access to health system’s
care providers.
“This is what people who feel bad need right now, right when
they begin to feel sick,†added Stephen K. Klasko, MD, president of
Thomas Jefferson University and CEO of Jefferson Health. “Working with
Quick’rCare allows us to expand our commitment to healthcare with no
address.â€
Overall, Apple products are designed to make healthcare more
human. Devices are meant to protect patient data and give easy
accessibility to everyone who uses Apple products. Patients are able to
access medical records and communicate from at home if needed. But
providers continue to question whether the information they are
receiving is accurate, as with new technologies, there isn’t always this
guarantee.
Posted by AGORACOM-JC
at 11:07 AM on Wednesday, December 18th, 2019
SPONSOR: BetterU Education Corp.
aims to provide access to quality education from around the world.
The company plans to bridge the prevailing gap in the education and job
industry and enhance the lives of its prospective learners by developing
an integrated ecosystem. Click here for more information.
Edtech Firm Springboard Raises $11 Mn From Reach Capital, Others To Expand Operations
Pearson Ventures, IFC, Costanoa Ventures, Learn Capital, and Blue Fog Capital also participated in funding round
Springboard will invest funds in expanding operations, adding more courses, hire more employees
Springboard has also partnered with US-based tech giant Microsoft
San Francisco and Bengaluru-based online edtech startup Springboard
has raised $11 Mn in a post-Series-A funding round led by Reach Capital.
Venture capital companies such as Pearson Ventures, International
Finance Corporation (IFC), as well as its existing investors Costanoa
Ventures, Learn Capital, and Blue Fog Capital also participated in the
funding round.
With the recently raised funds, Springboard will expand its
operations, add more courses, and bring more talent to the company. “We
will use this funding to grow our Indian presence with more courses in
design and software engineering and continue our expansion into
additional geographies,†said Vivek Kumar, Springboard India’s managing
director.
Though the current employee strength of the company stands at 130,
Springboard plans to increase the headcount to over 200 in the next few
quarters.
Springboard has also partnered with US-based tech giant Microsoft to
train and provide jobs to 5,000 students in the analytics profession
over the next three years through its new Data Analytics Career Track
platform, which is co-developed by the tech company.
Further, in this partnership, Microsoft will provide educational
content and access to its tools. On the other hand, Springboard will
provide mentorship, support and career services.
Founded in 2013 by Gautam Tambay and Parul Gupta, Springboard
is a workforce upskilling edtech startup that offers online courses and
extensive mentor-based learning for early and mid-level professionals
in data science, UX design, digital marketing, and other technology
areas. The company has so far raised $20 Mn in funding.
Highlighting the need for upskilling of developers which comes in
every three to five years, Kumar said that the company’s
industry-designed programmes, combined with in-depth, one-on-one
mentorship and career guidance, enable people to achieve their full
potential.
The company claims to have enrolled over 14K students for its
programmes worldwide. Notably, in 2019, the company has launched three
new programmes for tech learners in India. “Springboard plans to grow
its Indian presence with more courses in design and software
engineering,†Kumar was quoted as saying.
Kumar further claimed that for its skilling courses, the company has
so far maintained a 99.9% success rate in job guarantee programmes.
According to a report
by Google and KPMG, the edtech market is expected to have a significant
impact on the online education sector, which has the potential to touch
$1.96 Bn by 2021 from $247 Mn at present.
The Indian education market is vast, complex, and has innumerable
existing gaps. So, despite the proliferation of both Indian and foreign
edtech companies, there is still enough scope to leverage the upskilling
game.
In India, Springboard competes with startups such as Udacity,
Coursera, Udemy, and Progate which are also leveraging their online
platforms in helping tech employees upskill their skills and remain
relevant to the changing times.
Posted by AGORACOM-JC
at 10:12 AM on Wednesday, December 18th, 2019
SPONSOR: PRIMO NUTRACEUTICALS INC.
(CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV)
provides strategic capital to the thriving cannabis cultivation
sector through ownership and development of commercial real estate
properties. The company also offers fully built out turnkey facilities
equipped with state-of-the-art growing infrastructure to cannabis
growers and processors. Click here for more info.
Lawmakers pressure FDA to make clear guidelines on CBD
With the passing of the 2018 Farm Bill, farmers, manufacturers and consumers are keeping a watchful eye on the agency and how they might address compliance for the thousands of companies selling the product and the millions of consumers vying to use it.Â
June 25, 2019, Senator Ron Wyden sent a letter to the Department of Health and Human Services and the Food and Drug  Administration urging both entities to provide clarity around CBD products derived from hemp.
The FDA has been under a magnifying glass since hemp was declassified
as a schedule I drug, having formerly fallen under the thumb of the
Controlled Substances Act of 1970.
With the passing of the 2018 Farm Bill, farmers, manufacturers and
consumers are keeping a watchful eye on the agency and how they might
address compliance for the thousands of companies selling the product
and the millions of consumers vying to use it.
Yet silence and lack of clarification on a potential path towards
compliance for supplement producers has left many chomping at the bit
for the agency to come up with regulatory guidelines for selling Food
and dietary supplements containing CBD. In the interim, well-established
companies such as Next Green Wave, Inc. (Next
Green Wave, NGW:CSE | NXGWF:OTCQX) have continued to solidify their
position in the market, ready and able to serve the exponentially
growing demand of what promises to be a $20 plus billion-dollar
industry.
A Slow and Arduous Process
In Wyden’s letter, the lawmaker criticized the FDA’s indication that
it could take up to 3 to 5 years for the FDA to implement final
regulations for companies to lawfully sell CBD infused foods, calling
the suggestion “unacceptable.†Wyden wrote that he urges the FDA to
quickly implement “enforcement discretion guidelines†by August 1, then
issue an interim final rule pending a permanent rule so that companies
will have clarity on how CBD in food and dietary products will be
regulated.
This argument may have fallen on attentive ears, but as of the date
of this publication, the FDA has yet to provide any clear established
guidelines. Although the agency has wielded their powers against a
handful of “bad actorsâ€, their approach seems to be that of “wait and
see†with regards to due process.
The letter penned by Wyden also stressed the economic impact growers
in states like Oregon would benefit from by allowing CBD to be in more
products, but are halted until the FDA gives the okay that CBD in
ingestible products is lawful to sell and okay to use.
However, this isn’t the first letter Wyden
has sent to the agency regarding a regulatory pathway to CBD
commercialization. In January the lawmaker co-authored a letter with
Senator Jeff Merkley telling the FDA they must revamp current
legislation around offering CBD products. Both senators advised former
commissioner Scott Gottlieb to “immediately begin updating regulations
for hemp-derived CBD and other hemp-derived cannabinoids, and give U.S.
producers more flexibility in the production, consumption, and sale of
hemp products,†according to the letter.
FDA is listening to public demand for clear CBD regulations
The FDA has slowly but surely has been taking measures to develop
guidelines around selling CBD ingestible-products. In late May, the
agency held a public hearing allowing stakeholders the opportunity to
share their reasons why the FDA-regulation for CBD food and dietary
products is crucial, according to the Chicago Tribune.
The agency also gave a chance for the public to weigh in on CBD
regulation by opening a public docket for individuals to add comments.
The deadline to submit comments was July 16, and the agency received
over 3,000 comments, according to the Chicago Tribune. In conjunction
with the open docket, the FDA also published an article July 17 echoing the agency’s stance on CBD and concern for public safety.
“We recognize that there is significant public interest in these
products, for therapeutic purposes and otherwise,†the article said. “At
the same time, there are many unanswered questions about the science,
safety, and quality of many of these products. As we approach these
questions, we do so as a science-based regulatory agency committed to
our mission of protecting and promoting public health.â€
In the “Listening to and learning from stakeholders†section of the
article, the FDA insists that relative questions must be answered in
order to develop a clear pathway to regulate CBD products which include
the following:
How much CBD is safe to consume in a day? How does it vary depending on what form it’s taken?
Are there drug interactions that need to be monitored?
What are the impacts on special populations, like children, the elderly, and pregnant or lactating women?
What are the risks of long-term exposure?
In a second article published on the same day, the FDA stressed it has not approved any CBD products besides Epidiolex,
a drug which treats seizures caused by epilepsy. And is currently
working to figure out how CBD will affect body parts, special
populations and pets.
Since both the public hearing and window to submit comments to the
FDA have both passed, the agency says it will review submitted
information and intends to follow up with its findings “around the end
of summer/early fall,†according to the Chicago Tribune.
It is unclear if the FDA will tentatively meet this deadline, but the
agency will most likely continue to be pressured by lawmakers and the
public to provide a regulatory framework around the selling and
obtaining CBD food and dietary supplements.